False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: Does it represent a clinical problem?

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 5, 2008, Pages 1109-1112

  Orlopp, K ^a   von Lilienfeld Toal, M ^a,b   Marklein, G ^a   Reiffert, S M ^a   Welter, A ^a   Hahn Ast, C ^a   Purr, I ^a   Gorschluter M ^a   Molitor, E ^a   Glasmacher, A ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cut off level; Febrile neutropenia; Fungal infection

Indexed keywords

COTRIMOXAZOLE; GALACTOMANNAN; ITRACONAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BLOOD SAMPLING; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; NONHUMAN; NORMAL VALUE; PROSPECTIVE STUDY;

AGED; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; MANNANS; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; PROSPECTIVE STUDIES;

EID: 54549091209     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn308     Document Type: Article

References (14)

1. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis. Clin Infect Dis 2006; 42: 1417-27.
2. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
3. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-906.
4. Maertens JA, Klont R, Masson C et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007; 44: 1329-36.
5. Bart-Delabesse E, Basile M, Al Jijakli A et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of β-lactam treatments. J Clin Microbiol 2005; 43: 5214-20.
6. Aubry A, Porcher R, Bottero J et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with β-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006; 44: 389-94.
7. Mattei D, Rapezzi D, Mordini N et al. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol 2004; 42: 5362-3.
8. Adam O, Auperin A, Wilquin F et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38: 917-20.
9. Tanriover MD, Metan G, Altun B et al. False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. Eur J Intern Med 2005; 16: 489-91.
10. Lim ZY, Ho AY, Devereux S et al. False positive results of galactomannan ELISA assay in haemato-oncology patients: A single centre experience. J Infect 2007; 55: 201-2.
11. Machetti M, Furfaro E, Viscoli C. Galactomannan in piperacillin-tazobactam: How much and to what extent? Antimicrob Agents Chemother 2005; 49: 3984-5.
12. Machetti M, Majabo MJ, Furfaro E et al. Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis. J Antimicrob Chemother 2006; 58: 806-10.
13. Penack O, Schwartz S, Thiel E et al. Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clin Infect Dis 2004; 39: 1401-2; author reply 2-3.
14. Penack O, Rempf P, Graf B et al. False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam - is it still an issue? Diagn Microbiol Infect Dis 2008; 60: 117-20.